Edgewise Therapeutics (EWTX) Insider Trading & Ownership $14.31 +0.05 (+0.35%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$14.30 -0.01 (-0.03%) As of 08/1/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Edgewise Therapeutics (NASDAQ:EWTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.20%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$10.00MNumber OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$12.73M Get EWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Edgewise Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EWTX Insider Buying and Selling by Quarter Edgewise Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/2/2025Alan J RussellInsiderSell1,551$16.45$25,513.95 5/2/2025Joanne M DonovanCMOSell5,187$16.45$85,326.15 5/2/2025John R MooreGeneral CounselSell1,930$16.45$31,748.50 5/2/2025Kevin KochCEOSell4,276$16.45$70,340.20 5/2/2025R Michael CarruthersCFOSell1,314$16.45$21,615.30 4/3/2025Orbimed Advisors LlcDirectorBuy496,771$20.13$10,000,000.23 2/6/2025Alan J RussellInsiderSell1,200$30.13$36,156.00 2/5/2025Kevin KochCEOSell8,636$30.03$259,339.08 1/28/2025Joanne M DonovanCMOSell25,000$27.63$690,750.00 12/30/2024Alan J RussellInsiderSell100,000$27.37$2,737,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/24/2024Marc SemigranInsiderSell29,709$29.69$882,060.21 9/23/2024John R MooreGeneral CounselSell20,922$27.63$578,074.86 9/20/2024Alan J RussellInsiderSell75,000$28.27$2,120,250.00 9/20/2024Joanne M DonovanCMOSell7,162$28.29$202,612.98 9/20/2024John R MooreGeneral CounselSell50,000$28.37$1,418,500.00 9/20/2024R Michael CarruthersCFOSell125,092$28.57$3,573,878.44 (Data available from 1/1/2013 forward) EWTX Insider Trading Activity - Frequently Asked Questions Who is on Edgewise Therapeutics' Insider Roster? The list of insiders at Edgewise Therapeutics includes Alan J Russell, Behrad Derakhshan, Holdings A/S Novo, Joanne M Donovan, John R Moore, Jonathan C Fox, Kevin Koch, Marc Semigran, Orbimed Advisors Llc, Peter A Thompson, and R Michael Carruthers. Learn more on insiders at EWTX. What percentage of Edgewise Therapeutics stock is owned by insiders? 23.20% of Edgewise Therapeutics stock is owned by insiders. Learn more on EWTX's insider holdings. Which Edgewise Therapeutics insiders have been buying company stock? The following insiders have purchased EWTX shares in the last 24 months: Jonathan C Fox ($100,970.10), Orbimed Advisors Llc ($10,000,000.23), and Peter A Thompson ($4,999,995.00). How much insider buying is happening at Edgewise Therapeutics? Insiders have purchased a total of 962,173 EWTX shares in the last 24 months for a total of $15,100,965.33 bought. Which Edgewise Therapeutics insiders have been selling company stock? The following insiders have sold EWTX shares in the last 24 months: Alan J Russell ($6,529,138.00), Behrad Derakhshan ($124,533.38), Joanne M Donovan ($1,048,315.75), John R Moore ($2,065,311.32), Kevin Koch ($389,283.60), Marc Semigran ($882,060.21), and R Michael Carruthers ($5,056,482.61). How much insider selling is happening at Edgewise Therapeutics? Insiders have sold a total of 771,348 Edgewise Therapeutics shares in the last 24 months for a total of $16,704,863.66 sold. Edgewise Therapeutics Key ExecutivesDr. Peter A. Thompson FACP (Age 64)M.D., Co-Founder & Independent Chairman Compensation: $76kDr. Kevin Koch Ph.D. (Age 64)President, CEO & Director Compensation: $905.52kDr. Badreddin Edris Ph.D. (Age 37)Co-Founder & Independent Director Compensation: $43kDr. Behrad Derakhshan Ph.D. (Age 44)Chief Business Officer Compensation: $630.67kDr. Joanne M. Donovan M.D. (Age 67)Ph.D., Chief Medical Officer Compensation: $696.4kDr. Alan J. Russell Ph.D. (Age 54)Co-Founder, Chief Scientific Officer & Director Compensation: $657.52kMr. R. Michael Carruthers (Age 66)Chief Financial Officer Compensation: $386.01k1 recent tradesMr. John R. Moore (Age 60)General Counsel 1 recent tradesDr. Marc Semigran M.D. (Age 67)Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies TGTX Insider Ownership NUVL Insider Ownership CRSP Insider Ownership RYTM Insider Ownership LNTH Insider Ownership AXSM Insider Ownership PCVX Insider Ownership MRUS Insider Ownership CYTK Insider Ownership RNA Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:EWTX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
